November 2019
Core topics in this month’s edition include:
- Abrilada (adalimumab-afzb) - new biosimilar approval
- Adakveo (crizanlizumab) - new drug approval
- Givlaari (givosiran) - new drug approval
- Truxima (rituximab-abbs) - new biosimilar approval
- Ziextenzo (pegfilgrastim-bmez) - new biosimilar approval
Top